CD247 and neoplasm: In 1998, before CAR-T cells had gained significant momentum, Roberts and colleagues reported that neutrophils engineered to express an HIV-specific chimeric immune receptor (CIR) containing a CD3ζ intracellular domain showed improved cytotoxicity against tumor cells transfected with the HIV envelope [210].